We’ve all heard about the growing capabilities of GenAI, and how its use will slash spend on content generation. You may also have heard about how developers of GenAI tools are starting to face legal action for copyright and database right infringement relating to the “training” of their solutions. You may have heard less about the IP infringement risks faced by typical commercial users of GenAI tools. In this session, recorded on 21 February 2024, Alex Newman and James Shiel from Mills & Reeve consider those risks and how to mitigate them.

свернуть